|
SKYE Skye Bioscience Inc 1516551 |
| Balance Sheet |
|
Current Assets
|
79,808,229 |
|
Assets
|
81,535,660 |
|
Current Liabilities
|
5,624,223 |
|
Liabilities
|
5,732,285 |
|
Equity
|
75,803,375 |
|
Shares Out
|
30,338,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-17,064,377 |
|
Investing Cash Flow
|
-336,025 |
| Market Analysis |
Market Cap
|
164,130,090 |
|
Price
|
2.04 |
|
BVPS
|
2.50 |
|
PB
|
0.76 |
|
EPS
|
-3.91 |
|
PS
|
0.20 |
|
FCF
|
-17,400,402 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SKYE documents filed with the SEC.
SKYE Filings
Clear
